District of Columbia
District of Columbia
In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.
In Your State
Economic Impact In Your State: District of Columbia
Economic Impact
$2.8B
Total output supported by biopharmaceutical sector
$186.6M
Tax Revenue Generated
8,359
Total Jobs
3,809
Direct Jobs
294
Total Clinical Trials
$63.3 million
Invested in Clinical Trials
4,433
Total Economic Impact of Clinical Trial Investments
$106.9 million
Invested in Clinical Trials